28 Mar Latest pharmaceutical translation news: Industry pushes for new drugs

Pharmaceutical research continues unabated. As time goes on, more and more drugs are emerging to treat diseases of all kinds. This means that there is an increasing need for pharmaceutical translation, for example, to translate the instructions for drugs into other languages. Here we take a look at the latest developments in the pharmaceutical industry.

Highlights for pharmaceutical translation

1- More than 1,300 cancer drugs and vaccines

The pharmaceutical industry is now developing more than 1,300 cancer drugs and vaccines. Survival rates for cancer patients have doubled in the last 40 years and are likely to continue to grow in the coming years thanks to increased early diagnosis and, above all, progress in drug therapies.

2- Biological treatment for atopic dermatitis approved

The European Commission (EC) has approved Adtralza (tralokinumab) for the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic treatment. The European Commission approval makes it the first high-affinity humanised monoclonal antibody specifically approved to block and inhibit the cytokine IL-13, a key factor in the signs and symptoms of atopic dermatitis.

3- Importance of drug localisation

A pan-European study concludes the importance of localising drug manufacturing in Europe to cope with future crises. During the pandemic, despite major constraints, such as the closure of countries (e.g. Italy, one of the main producers of active ingredients) or the increase in demand for certain drugs (e.g. ICU drugs), the pharmaceutical industry has demonstrated its resilience and has been able to protect patients.

4- Quick and easy manufacture of nanomedicines

Researchers at Queen’s University Belfast are using microfluidics to manufacture particles to encapsulate drugs and biological products for cellular treatment and imaging components. The technology used comes from the company Dolomite, which offers a range of microfluidic systems, components and speciality chemicals – including pumps, chips, connectors, temperature controllers, sensors, accessories and custom components – as well as software for analysis or automation.